Atlas Trials

Dual-energy SPEctral CT to Evaluate Response to First-line Therapies in Patients With Metastatic Clear Cell REnal Cancer

Clinical trial NCT06863857 · RECRUITING

Trial details

NCT number
NCT06863857
Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Status
RECRUITING
Study type
OBSERVATIONAL
Renal Cancer
Start date
2024-09-30
Primary completion
2027-06-18
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.